LOX and systemic sclerosis: In SSc, LOX staining was prominently upregulated in the skin (2.5 ± 0.6% Control vs. 4.5 ± 1.1% SSc) and lung (3.9 ± 1.9% Control vs. 4.5 ± 1.1% SSc) tissues (Figure 1B).